
Intravenous N-acetylcysteine in Pediatric Patients With Nonacetaminophen Acute Liver Failure: A Placebo-Controlled Clinical Trial
N-acetylcysteine (NAC) was found to improve transplantation-free survival in only those adults with nonacetaminophen (non-APAP) acute liver failure (ALF) and grade 1-2 hepatic encephalopathy (HE).